Sustainability Challenges and Opportunities in Oligonucleotide Manufacturing

[Image: see text] With a renewed and growing interest in therapeutic oligonucleotides across the pharmaceutical industry, pressure is increasing on drug developers to take more seriously the sustainability ramifications of this modality. With 12 oligonucleotide drugs reaching the market to date and...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrews, Benjamin I., Antia, Firoz D., Brueggemeier, Shawn B., Diorazio, Louis J., Koenig, Stefan G., Kopach, Michael E., Lee, Heewon, Olbrich, Martin, Watson, Anna L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154579/
https://www.ncbi.nlm.nih.gov/pubmed/33253568
http://dx.doi.org/10.1021/acs.joc.0c02291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154579/
https://www.ncbi.nlm.nih.gov/pubmed/33253568
http://dx.doi.org/10.1021/acs.joc.0c02291

Ejemplares similares